• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anticipating the long-term cardiovascular effects of COVID-19.

作者信息

Becker Richard C

机构信息

Department of Medicine, University of Cincinnati Heart and Circulation Research Institute, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA.

出版信息

J Thromb Thrombolysis. 2020 Oct;50(3):512-524. doi: 10.1007/s11239-020-02266-6.

DOI:10.1007/s11239-020-02266-6
PMID:32880795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7467860/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/90e1707ba663/11239_2020_2266_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/98ba7d5dcdab/11239_2020_2266_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/961738143ea6/11239_2020_2266_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/f5c11444f009/11239_2020_2266_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/7c7d658c9ecd/11239_2020_2266_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/61a8650f17dd/11239_2020_2266_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/e06770a7867a/11239_2020_2266_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/9d52f5bc0989/11239_2020_2266_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/90e1707ba663/11239_2020_2266_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/98ba7d5dcdab/11239_2020_2266_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/961738143ea6/11239_2020_2266_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/f5c11444f009/11239_2020_2266_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/7c7d658c9ecd/11239_2020_2266_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/61a8650f17dd/11239_2020_2266_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/e06770a7867a/11239_2020_2266_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/9d52f5bc0989/11239_2020_2266_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d024/7467860/90e1707ba663/11239_2020_2266_Fig8_HTML.jpg

相似文献

1
Anticipating the long-term cardiovascular effects of COVID-19.预测新型冠状病毒肺炎的长期心血管影响。
J Thromb Thrombolysis. 2020 Oct;50(3):512-524. doi: 10.1007/s11239-020-02266-6.
2
Unique Patterns of Cardiovascular Involvement in Coronavirus Disease-2019.2019冠状病毒病中心血管受累的独特模式。
J Card Fail. 2020 Jun;26(6):466-469. doi: 10.1016/j.cardfail.2020.05.006. Epub 2020 May 14.
3
Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis.2019年冠状病毒病（COVID-19）与心血管风险：一项荟萃分析。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):527-528. doi: 10.1016/j.pcad.2020.05.001. Epub 2020 May 7.
4
The kidney and COVID-19 patients - Important considerations.肾脏与新冠病毒肺炎患者——重要考量因素
Travel Med Infect Dis. 2020 Sep-Oct;37:101831. doi: 10.1016/j.tmaid.2020.101831. Epub 2020 Aug 1.
5
Cardiovascular complications in COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎的心血管并发症：一项系统评价与荟萃分析
J Infect. 2020 Aug;81(2):e139-e141. doi: 10.1016/j.jinf.2020.05.068. Epub 2020 Jun 3.
6
Call to action for the cardiovascular side of COVID-19.针对新冠病毒病心血管方面的行动呼吁。
Eur Heart J. 2020 May 14;41(19):1796-1797. doi: 10.1093/eurheartj/ehaa301.
7
Towards precision management of cardiovascular patients with COVID-19 to reduce mortality.实现对新冠肺炎心血管疾病患者的精准管理以降低死亡率。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):529-530. doi: 10.1016/j.pcad.2020.04.012. Epub 2020 Apr 28.
8
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.一种急性呼吸道感染遭遇了最常见的非传染性流行病——新冠肺炎与心血管疾病。
JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.
9
COVID-19 in patients with cardiovascular diseases.心血管疾病患者中的新型冠状病毒肺炎
Arch Cardiovasc Dis. 2020 Apr;113(4):225-226. doi: 10.1016/j.acvd.2020.03.009. Epub 2020 Mar 31.
10
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.CAPACITY-COVID：一项欧洲登记研究，旨在确定心血管疾病在新冠疫情中的作用。
Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.

引用本文的文献

1
Hypercoagulopathy as a severe Long-term complication of post SARS-CoV-19 infection.高凝状态作为新冠病毒感染后一种严重的长期并发症。
Hum Pathol Rep. 2022 Mar;27:300595. doi: 10.1016/j.hpr.2022.300595. Epub 2022 Feb 3.
2
STEMI in Times of Crisis: Comparative Analysis During Pandemic and War.危机时期的ST段抬高型心肌梗死：大流行和战争期间的比较分析
J Clin Med. 2025 Mar 4;14(5):1720. doi: 10.3390/jcm14051720.
3
Role of Gut Microbiota in Long COVID: Impact on Immune Function and Organ System Health.肠道微生物群在长期新冠中的作用：对免疫功能和器官系统健康的影响

本文引用的文献

1
Renin-angiotensin aldosterone inhibitor use at hospital discharge among patients with moderate to severe acute kidney injury and its association with recurrent acute kidney injury and mortality.中重度急性肾损伤患者出院时肾素-血管紧张素-醛固酮抑制剂的使用情况及其与急性肾损伤复发和死亡率的关联。
Kidney Int. 2021 May;99(5):1202-1212. doi: 10.1016/j.kint.2020.08.022. Epub 2020 Sep 8.
2
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection.人诱导多能干细胞衍生的心肌细胞易受新冠病毒感染。
Cell Rep Med. 2020 Jul 21;1(4):100052. doi: 10.1016/j.xcrm.2020.100052. Epub 2020 Jun 29.
3
COVID-19 in Portugal: exploring the immediate psychological impact on the general population.
Arch Microbiol Immunol. 2025;9(1):38-53. Epub 2025 Feb 4.
4
A deeper look at long-term effects of COVID-19 on myocardial function in survivors with no prior heart diseases: a GRADE approach systematic review and meta-analysis.深入研究新冠病毒病对无既往心脏病幸存者心肌功能的长期影响：采用GRADE方法进行的系统评价和荟萃分析
Front Cardiovasc Med. 2024 Nov 19;11:1458389. doi: 10.3389/fcvm.2024.1458389. eCollection 2024.
5
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成：区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
6
How the immune response to the structural proteins of SARS-CoV-2 affects the retinal vascular endothelial cells: an immune thrombotic and/or endotheliopathy process with in silico modeling.新冠病毒结构蛋白引起的免疫反应如何影响视网膜血管内皮细胞：一种免疫血栓形成和/或内皮病变过程的计算机模拟研究。
Immunol Res. 2024 Feb;72(1):50-71. doi: 10.1007/s12026-023-09412-1. Epub 2023 Aug 29.
7
Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients.新型冠状病毒肺炎对自主心血管系统的影响：恢复期患者的心率变异性和血流动力学不稳定性。
Tex Heart Inst J. 2023 Aug 21;50(4). doi: 10.14503/THIJ-22-7952.
8
Cardiac evaluation of hospitalized children with 2019 coronavirus (COVID-19) infection at a single large quaternary center.在一家大型四级医疗中心对2019冠状病毒病（COVID-19）感染住院儿童进行心脏评估。
Heliyon. 2023 Jun;9(6):e17395. doi: 10.1016/j.heliyon.2023.e17395. Epub 2023 Jun 19.
9
Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms.新型冠状病毒肺炎患者鼻腔、咽部和唾液分泌型IgA水平的变化以及通过鼻内和口服联合给予含有机会性微生物抗原的药物来纠正其分泌的可能性。
Drugs Context. 2023 Jun 12;12. doi: 10.7573/dic.2022-10-4. eCollection 2023.
10
Cost-Effectiveness Analysis of COVID-19 Inactivated Vaccines in Reducing the Economic Burden of Ischaemic Stroke after SARS-CoV-2 Infection.新型冠状病毒灭活疫苗在减轻新冠病毒感染后缺血性卒中经济负担方面的成本效益分析
Vaccines (Basel). 2023 May 7;11(5):957. doi: 10.3390/vaccines11050957.
葡萄牙的 COVID-19 疫情：探究其对普通民众的即时心理影响。
Psychol Health Med. 2021 Jan;26(1):44-55. doi: 10.1080/13548506.2020.1808236. Epub 2020 Aug 18.
4
Indications for and Findings on Transthoracic Echocardiography in COVID-19.COVID-19 经胸超声心动图的适应证和发现。
J Am Soc Echocardiogr. 2020 Oct;33(10):1278-1284. doi: 10.1016/j.echo.2020.06.009. Epub 2020 Jun 17.
5
Postdischarge thrombosis and hemorrhage in patients with COVID-19.COVID-19 患者出院后的血栓形成和出血。
Blood. 2020 Sep 10;136(11):1342-1346. doi: 10.1182/blood.2020007938.
6
SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.严重急性呼吸综合征冠状病毒 2 型与神经系统：从临床特征到分子机制。
Int J Mol Sci. 2020 Jul 31;21(15):5475. doi: 10.3390/ijms21155475.
7
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19).COVID-19 患者近期康复后的心血管磁共振成像结果。
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273. doi: 10.1001/jamacardio.2020.3557.
8
Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials.gov.《ClinicalTrials.gov 上注册的 COVID-19 研究的特征和证据强度》
JAMA Intern Med. 2020 Oct 1;180(10):1398-1400. doi: 10.1001/jamainternmed.2020.2904.
9
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases.心脏感染与确诊 COVID-19 尸检病例中 SARS-CoV-2 的关联。
JAMA Cardiol. 2020 Nov 1;5(11):1281-1285. doi: 10.1001/jamacardio.2020.3551.
10
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.SARS-CoV-2 反应性 T 细胞在健康供体和 COVID-19 患者中的研究。
Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29.